New course offers hope to dementia sufferersMarch 24, 2005The first nationally accredited training course aimed at improving the lives of people with dementia is being launched at the University of Sunderland. The distance learning course for professionals will help further raise the level of care offered to thousands of people across the country living with dementia. Sunderland has teamed up with the Alzheimer's society, BUPA care homes and the Joseph Rowntree Foundation to provide the new course, 'an introduction to dementia care'. Through open learning, the use of videos, group discussion and working with people with dementia, the course will encourage staff to view dementia care as a career choice and help in the understanding of the illness. Vicki Lawson-Brown, senior lecturer in health studies at the university said: "This course recognises the attitude, expertise and knowledge needed to deliver successful dementia care. "It's an exciting new development to provide a better quality of care for people who have dementia, treating them with the respect and dignity they deserve. We welcome the opportunity to recognise the work of care staff in this field." The new course is part of a range of Joseph Rowntree programmes awarded to the University of Sunderland by the trust two years ago. Studies have shown that up to 75 per cent of people living in nursing and residential care homes have Alzheimer's or another form of dementia. The Alzheimer's society hopes that all care providers will eventually use the course to help improve training for those working with people with dementia. Daren Felgate, the Alzheimer's society's training and development manager, said: "We hope this course will become the key introductory course for care workers helping people with dementia. "Working with people with dementia is often seen as difficult and challenging, but with the right support many care staff will see it is the most rewarding work they have ever done." The course has already been piloted through four BUPA care homes and the Joseph Rowntree Foundation in York. It will be launched at the Royal Society in London on April 22, where speakers from BUPA and the Alzheimer's Society will be highlighting the importance of effective dementia care training. Sunderland, University of |
|||||||||||||||||||||
| Related Alzheimer Disease Current Events and Alzheimer Disease News Articles Delirium in hospitalized adults: Situation critical, no relief available Every year as many as seven million adults in the United States experience delirium during hospitalization. New data demonstrate potential for early detection of Alzheimer's disease Data published in the June issue of the Journal of Alzheimer's Disease demonstrated that minimally-invasive biospectroscopy was able to identify changes in oxidative stress (OS) levels in blood plasma, which may prove to be a useful biomarker in the early detection of Alzheimer's disease. Another McGill/JGH breakthrough opens door to early Alzheimer's diagnosis A new diagnostic technique which may greatly simplify the detection of Alzheimer's disease has been discovered by researchers at McGill University and the affiliated Lady Davis Institute for Medical Research at Montreal's Jewish General Hospital (JGH). Measuring brain atrophy in patients with mild cognitive impairment Scientists at the University of California, San Diego School of Medicine have shown that a fully automated procedure called Volumetric MRI - which measures the "memory centers" of the brain and compares them to expected size - is effective in predicting the progression from mild cognitive impairment (MCI) to Alzheimer's disease. Commonly used medications may produce cognitive impairment in older adults Many drugs commonly prescribed to older adults for a variety of common medical conditions including allergies, hypertension, asthma, and cardiovascular disease appear to negatively affect the aging brain causing immediate but possibly reversible cognitive impairment, including delirium, in older adults. Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug. New test for mysterious metabolic diseases developed at Stanford/Packard Scientists at Stanford University School of Medicine have devised a much-needed way to monitor and find treatments for a mysterious and devastating group of metabolic diseases that arise from mutations in cells' fuel-burning mechanism. Recalibrating 'fight or flight' A Canadian/U.S. research team has reported a novel approach to stimulating recovery from chronic stress disorders. Details of the therapeutic model, which exploits the natural dynamics of the body's "fight or flight" system, are published January 23 in the open-access journal PLoS Computational Biology Vitamin B does not slow cognitive decline in Alzheimer's A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease. Protecting patient privacy the new fashioned way Protecting patient privacy has been recognized as the duty of health-care providers for about as long as doctors have seen patients. In 1996 that duty became a legal obligation when Congress passed the Health Insurance Portability and Accountability Act. More Alzheimer Disease Current Events and Alzheimer Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||